---
id: 064
title: Azole Mechanism of Action
category: antimicrobials
subcategory: azoles
tags: [azoles, mechanism, ergosterol, lanosterol-demethylase, fungistatic]
difficulty: medium
---

## Question

What is the mechanism of action for azole antifungals? Use the **"AZOLES Block ERGOSTEROL"** mnemonic.

## Answer

### **"AZOLES Block ERGOSTEROL" Mnemonic:**

**AZOLES:**
- **A**ntifungal via CYP450 inhibition
- **Z**aps 14α-lanosterol demethylase
- **O**ther sterols accumulate (toxic)
- **L**eads to membrane dysfunction
- **E**rgosterol synthesis blocked
- **S**tatic (fungistatic, not fungicidal)

**Block ERGOSTEROL:**
- **B**locks fungal CYP450
- **L**anosterol demethylase enzyme (14α)
- **O**utcome: no ergosterol production
- **C**ell membrane integrity lost
- **K**ills fungi slowly (fungistatic)

**ERGOSTEROL:**
- **E**ssential fungal sterol (like cholesterol in humans)
- **R**equired for membrane structure
- **G**rowth inhibited without it
- **O**bligatory for fungal survival
- **S**elective toxicity (humans use cholesterol, not ergosterol)
- **T**arget: fungal CYP51 enzyme
- **E**levates toxic sterol intermediates
- **R**esults in membrane permeability
- **O**utcome: growth inhibition
- **L**ittle effect on human cells (selective)

### **Detailed Mechanism:**

**Step 1: Enzyme Inhibition**
- Azoles bind to **fungal cytochrome P450 enzyme** (lanosterol 14α-demethylase, also called CYP51)
- This enzyme normally converts **lanosterol → ergosterol**
- Azole binding blocks this conversion

**Step 2: Ergosterol Depletion**
- **Ergosterol is essential** component of fungal cell membranes (analogous to cholesterol in mammals)
- Depletion causes **loss of membrane integrity**
- Increased membrane permeability

**Step 3: Toxic Sterol Accumulation**
- Upstream sterols accumulate (lanosterol, 14-methylated sterols)
- These are **toxic** to fungal cells
- Further disrupts membrane function

**Step 4: Growth Inhibition**
- Combined effects → **fungistatic** (inhibit growth, not kill)
- At high concentrations: may be fungicidal for some species

### **Selectivity:**

| Feature | Fungi | Humans | Selectivity? |
|---------|-------|--------|--------------|
| **Membrane sterol** | Ergosterol | Cholesterol | ✅ YES |
| **Target enzyme** | CYP51 (14α-demethylase) | Different CYPs | ✅ YES |
| **Azole affinity** | High for fungal CYP51 | Low for human CYPs | ✅ YES |

**Key Point:** Azoles are **selectively toxic** because they preferentially bind fungal CYP51 over human CYP enzymes

## Key Points

### **Pharmacodynamics:**

**Fungistatic vs Fungicidal:**
- **Fungistatic** for most pathogens (*Candida*, *Aspergillus*)
- May be **fungicidal** at high concentrations or for certain species (*Cryptococcus*)
- **Time-dependent** killing (not concentration-dependent)

**Resistance Mechanisms:**
1. **Upregulation of target enzyme** (CYP51/ERG11) → more enzyme produced
2. **Mutations in CYP51** → reduced azole binding
3. **Efflux pumps** → pump drug out of cell (CDR1, CDR2, MDR1)
4. **Alternative ergosterol synthesis pathways**

### **Cross-Resistance:**
- Azole resistance can affect **all azoles** (class effect)
- However, newer azoles (voriconazole, posaconazole, isavuconazole) may retain activity against some fluconazole-resistant strains

### **Clinical Implications:**

**Why TDM Matters:**
- Fungistatic mechanism requires **sustained drug levels**
- Subtherapeutic levels → treatment failure
- **AUC/MIC ratio** predicts efficacy (time-dependent)

**Why Combination Therapy Sometimes Used:**
- Azoles (fungistatic) + echinocandins (fungicidal) = potential synergy
- Used for refractory infections
- Evidence mixed for routine combination

### **Comparison to Other Antifungal Classes:**

| Class | Mechanism | Effect | Target |
|-------|-----------|--------|--------|
| **Azoles** | ↓ Ergosterol synthesis | Fungistatic | CYP51 (14α-demethylase) |
| **Polyenes** (ampho B) | Bind ergosterol | **Fungicidal** | Ergosterol itself |
| **Echinocandins** | ↓ β-glucan synthesis | **Fungicidal** | β-1,3-glucan synthase |
| **Flucytosine** | ↓ DNA/RNA synthesis | Fungistatic | Pyrimidine metabolism |

## Sources

- [StatPearls NBK551581: Antifungal Ergosterol Synthesis Inhibitors]
- [UpToDate: Pharmacology of Azoles]
- [PMC7712939: Isavuconazole Mechanism]

## Media

N/A
